Sanofi-Aventis Invests $65M in Cambridge, Massachusetts Growth
07/08/2010
"We believe that Cambridge is really the heart of oncology today,'' Hanspeter Spek, president of Sanofi-Aventis global operations, said in a company conference call this year. "We intend to benefit from this environment as a neighbor.''
Massachusetts is banking on the pharmaceutical industry to buoy the state's economy. Two years ago Governor Deval Patrick began a $1 billion, 10-year plan to offer tax incentives to life sciences companies. Last year, 26 companies received a total of $24.5 million.
Sanofi-Aventis has applied for $2.45 million in state tax credits from the Life Sciences Center, and will ask for another $6.5 million over the next four years.
Several other foreign pharmaceutical companies have facilities around Boston, such as Novartis, Merck, GlaxoSmithKline, and AstraZeneca.
Project Announcements
ContiTech Expands Mount Pleasant, Iowa, Production Operations
12/07/2025
Modular Closets Plans Kernersville, North Carolina, Production Operations
12/07/2025
QMP Plans Walterboro, South Carolina, Operations
12/06/2025
Ninth Avenue Foods Plans Longview, Texas, Production Operations
12/06/2025
LayerZero Power Systems Expands Streetsboro, Ohio, Manufacturing Operations
12/06/2025
BioStem Technologies Plans Boca Raton, Florida, Headquarters Operations
12/06/2025
Most Read
-
Rethinking Local Governments Through Consolidation and Choice
Q3 2025
-
First Person: Filter King’s Expansion Playbook
Q3 2025
-
Rethinking Auto Site Strategy in the Age of Tariffs and Powertrain Shifts
Q3 2025
-
Lead with Facts, Land the Deal
Q3 2025
-
How Canada Stays Competitive
Q3 2025
-
America’s Aerospace Reboot
Q3 2025
-
The Permit Puzzle and the Path to Groundbreaking
Q3 2025